chloromethanesulfonohydrazide | 28059-26-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磺酸及其衍生物
• 英文名称: chloromethanesulfonohydrazide
• 英文别名: chloromethanesulfonic acid hydrazide；Chlormethansulfonsaeurehydrazid；Chlormethansulfonylhydrazid；Chlormethansulfonylhydrazin
• CAS: 28059-26-9
• 化学式: CH₅ClN₂O₂S
• mdl: MFCD19232665
• 分子量: 144.582
• InChiKey: SRSMTPLLSHKLPS-UHFFFAOYSA-N

物化性质

• 沸点：
  286.6±42.0 °C(Predicted)
• 密度：
  1.607±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.7
• 重原子数：
  7
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  80.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  chloromethanesulfonohydrazide 、 三氯硫氯甲烷 以 乙二醇二甲醚 为溶剂， 生成 N-Chlormethansulfonyl-N'-trichlormethansulfenylhydrazin
  参考文献：
  名称：

  Senning,A., Acta Chemica Scandinavica (1947), 1970, vol. 24, p. 221 - 227

  摘要：

  DOI：
• 作为产物：
  描述：

  氯甲磺酰氯 在 肼 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 2.0h， 生成 chloromethanesulfonohydrazide
  参考文献：
  名称：

  Novel triacsin C analogs as potential antivirals against rotavirus infections

  摘要：

  Recently our group has demonstrated that cellular triglyceride (TG) levels play an important role in rotavirus replication. In this study, we further examined the roles of the key enzymes for TG synthesis (lipogenesis) in the replication of rotaviruses by using inhibitors of fatty acid synthase, long chain fatty acid acyl-CoA synthetase (ACSL), and diacylglycerol acyltransferase and acyl-CoA:cholesterol acyltransferase in association with lipid droplets of which TG is a major component. Triacsin C, a natural ACSL inhibitor from Streptomyces aureofaciens, was found to be highly effective against rotavirus replication. Thus, novel triacsin C analogs were synthesized and evaluated for their efficacies against the replication of rotaviruses in cells. Many of the analogs significantly reduced rotavirus replication, and one analog (1e) was highly effective at a nanomolar concentration range (ED50 0.1 mu M) with a high therapeutic index in cell culture. Our results suggest a crucial role of lipid metabolism in rotavirus replication, and triacsin C and/or its analogs as potential therapeutic options for rotavirus infections. (C) 2012 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2012.02.010